Cargando…

A survey of proteomic biomarkers for heterotopic ossification in blood serum

BACKGROUND: Heterotopic ossification (HO) is a significant problem for wounded warriors surviving high-energy blast injuries; however, currently, there is no biomarker panel capable of globally characterizing, diagnosing, and monitoring HO progression. The aim of this study was to identify biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Edsberg, Laura E., Crowgey, Erin L., Osborn, Patrick M., Wyffels, Jennifer T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418723/
https://www.ncbi.nlm.nih.gov/pubmed/28472996
http://dx.doi.org/10.1186/s13018-017-0567-2
_version_ 1783234098091786240
author Edsberg, Laura E.
Crowgey, Erin L.
Osborn, Patrick M.
Wyffels, Jennifer T.
author_facet Edsberg, Laura E.
Crowgey, Erin L.
Osborn, Patrick M.
Wyffels, Jennifer T.
author_sort Edsberg, Laura E.
collection PubMed
description BACKGROUND: Heterotopic ossification (HO) is a significant problem for wounded warriors surviving high-energy blast injuries; however, currently, there is no biomarker panel capable of globally characterizing, diagnosing, and monitoring HO progression. The aim of this study was to identify biomarkers for HO using proteomic techniques and blood serum. METHODS: Isobaric tags for relative and absolute quantitation (iTRAQ) was used to generate a semi-quantitative global proteomics survey of serum from patients with and without heterotopic ossification. Leveraging the iTRAQ data, a targeted selection reaction monitoring mass spectrometry (SRM-MS) assay was developed for 10 protein candidates: alkaline phosphatase, osteocalcin, alpha-2 type I collagen, collagen alpha-1(V) chain isoform 2 preprotein, bone sialoprotein 2, phosphatidate phosphatase LPIN2, osteomodulin, protein phosphatase 1J, and RRP12-like protein. RESULTS: The proteomic survey of serum from both healthy and disease patients includes 1220 proteins and was enriched for proteins involved in the response to elevated platelet Ca(+2), wound healing, and extracellular matrix organization. Proteolytic peptides from three of the ten SRM-MS proteins, osteocalcin preprotein, osteomodulin precursor, and collagen alpha-1(v) chain isoform 2 preprotein from serum, are potential clinical biomarkers for HO. CONCLUSIONS: This study is the first reported SRM-MS analysis of serum from individuals with and without heterotopic ossification, and differences in the serum proteomic profile between healthy and diseased subjects were identified. Furthermore, our results indicate that normal wound healing signals can impact the ability to identify biomarkers, and a multi-protein panel assay, including osteocalcin preproprotein, osteomodulin precursor, and collagen alpha-1(v) chain isoform 2 preprotein, may provide a solution for HO detection and monitoring. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13018-017-0567-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5418723
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54187232017-05-08 A survey of proteomic biomarkers for heterotopic ossification in blood serum Edsberg, Laura E. Crowgey, Erin L. Osborn, Patrick M. Wyffels, Jennifer T. J Orthop Surg Res Research Article BACKGROUND: Heterotopic ossification (HO) is a significant problem for wounded warriors surviving high-energy blast injuries; however, currently, there is no biomarker panel capable of globally characterizing, diagnosing, and monitoring HO progression. The aim of this study was to identify biomarkers for HO using proteomic techniques and blood serum. METHODS: Isobaric tags for relative and absolute quantitation (iTRAQ) was used to generate a semi-quantitative global proteomics survey of serum from patients with and without heterotopic ossification. Leveraging the iTRAQ data, a targeted selection reaction monitoring mass spectrometry (SRM-MS) assay was developed for 10 protein candidates: alkaline phosphatase, osteocalcin, alpha-2 type I collagen, collagen alpha-1(V) chain isoform 2 preprotein, bone sialoprotein 2, phosphatidate phosphatase LPIN2, osteomodulin, protein phosphatase 1J, and RRP12-like protein. RESULTS: The proteomic survey of serum from both healthy and disease patients includes 1220 proteins and was enriched for proteins involved in the response to elevated platelet Ca(+2), wound healing, and extracellular matrix organization. Proteolytic peptides from three of the ten SRM-MS proteins, osteocalcin preprotein, osteomodulin precursor, and collagen alpha-1(v) chain isoform 2 preprotein from serum, are potential clinical biomarkers for HO. CONCLUSIONS: This study is the first reported SRM-MS analysis of serum from individuals with and without heterotopic ossification, and differences in the serum proteomic profile between healthy and diseased subjects were identified. Furthermore, our results indicate that normal wound healing signals can impact the ability to identify biomarkers, and a multi-protein panel assay, including osteocalcin preproprotein, osteomodulin precursor, and collagen alpha-1(v) chain isoform 2 preprotein, may provide a solution for HO detection and monitoring. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13018-017-0567-2) contains supplementary material, which is available to authorized users. BioMed Central 2017-05-04 /pmc/articles/PMC5418723/ /pubmed/28472996 http://dx.doi.org/10.1186/s13018-017-0567-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Edsberg, Laura E.
Crowgey, Erin L.
Osborn, Patrick M.
Wyffels, Jennifer T.
A survey of proteomic biomarkers for heterotopic ossification in blood serum
title A survey of proteomic biomarkers for heterotopic ossification in blood serum
title_full A survey of proteomic biomarkers for heterotopic ossification in blood serum
title_fullStr A survey of proteomic biomarkers for heterotopic ossification in blood serum
title_full_unstemmed A survey of proteomic biomarkers for heterotopic ossification in blood serum
title_short A survey of proteomic biomarkers for heterotopic ossification in blood serum
title_sort survey of proteomic biomarkers for heterotopic ossification in blood serum
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418723/
https://www.ncbi.nlm.nih.gov/pubmed/28472996
http://dx.doi.org/10.1186/s13018-017-0567-2
work_keys_str_mv AT edsberglaurae asurveyofproteomicbiomarkersforheterotopicossificationinbloodserum
AT crowgeyerinl asurveyofproteomicbiomarkersforheterotopicossificationinbloodserum
AT osbornpatrickm asurveyofproteomicbiomarkersforheterotopicossificationinbloodserum
AT wyffelsjennifert asurveyofproteomicbiomarkersforheterotopicossificationinbloodserum
AT edsberglaurae surveyofproteomicbiomarkersforheterotopicossificationinbloodserum
AT crowgeyerinl surveyofproteomicbiomarkersforheterotopicossificationinbloodserum
AT osbornpatrickm surveyofproteomicbiomarkersforheterotopicossificationinbloodserum
AT wyffelsjennifert surveyofproteomicbiomarkersforheterotopicossificationinbloodserum